Effects of 6% hydroxyethyl starch 130/0.4 on postoperative blood loss and kidney injury in off-pump coronary arterial bypass grafting: A retrospective study

Medicine (United States)

Volumn 96, Issue 18, 2017, Pages

  Min, Jeong Jin ^a   Cho, Hyun Sung ^a   Jeon, Suyong ^a   Lee, Jong Hwan ^a   Lee, Jeong Jin ^a   Lee, Young Tak ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

acute kidney injury; colloid; hydroxyethyl starch; off pump coronary arterial bypass grafting; postoperative bleeding

Indexed keywords

HETASTARCH; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPENSITY SCORE; REOPERATION; RETROSPECTIVE STUDY; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; MIDDLE AGED; RISK; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; AGED; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INCIDENCE; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; POSTOPERATIVE HEMORRHAGE; PROPENSITY SCORE; REOPERATION; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME;

EID: 85019230636     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000006801     Document Type: Article

References (36)

1. Gillies MA, Habicher M, Jhanji S, et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth 2014;112:25-34.
2. Muralidhar K, Garg R, Mohanty S, et al. Influence of colloid infusion on coagulation during off-pump coronary artery bypass grafting. Indian J Anaesth 2010;54:147-53.
3. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001;72:527-33. discussion 534.
4. Roche AM, James MF, Bennett-Guerrero E, et al. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids. Anesth Analg 2006;102:1274-9.
5. Jacob M, Fellahi JL, Chappell D, et al. The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis. Crit Care 2014;18:656.
6. Van Der Linden P, James M, Mythen M, et al. Safety of modern starches used during surgery. Anesth Analg 2013;116:35-48.
7. Martin C, Jacob M, Vicaut E, et al. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013;118:387-94.
8. Esper SA, Subramaniam K, Tanaka KA. Pathophysiology of cardiopulmonary bypass: Current strategies for the prevention and treatment of anemia, coagulopathy, and organ dysfunction. Semin Cardiothorac Vasc Anesth 2014;18:161-76.
9. Lee JS, Ahn SW, Song JW, et al. Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery. Circ J 2011;75:2397-402.
10. Kim JY, Joung KW, Kim KM, et al. Relationship between a perioperative intravenous fluid administration strategy and acute kidney injury following off-pump coronary artery bypass surgery: an observational study. Crit Care 2015;19:350.
11. Okusa MD, Davenport A. Reading between the (guide)lines - the KDIGO practice guideline on acute kidney injury in the individual patient. Kidney Int 2014;85:39-48.
12. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8: R204-12.
13. Karkouti K, O'Farrell R, Yau TM, et al. Reducing Bleeding in Cardiac Surgery Research GPrediction of massive blood transfusion in cardiac surgery. Can J Anaesth 2006;53:781-94.
14. Vuylsteke A, Pagel C, Gerrard C, et al. The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg 2011;39:924-30.
15. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2012;144:223-30.
16. Nielsen VG. Effects of Hextend hemodilution on plasma coagulation kinetics in the rabbit: role of factor XIII-mediated fibrin polymer crosslinking. J Surg Res 2006;132:17-22.
17. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005;49:1163-71.
18. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, et al. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 2009;108:30-6.
19. Hartog CS, Reuter D, Loesche W, et al. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 2011;37: 1725-37.
20. de Jonge E, Levi M, Buller HR, et al. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects. Intensive Care Med 2001;27:1825-9.
21. Niemi T, Schramko A, Kuitunen A, et al. Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Scand J Surg 2008;97:259-65.
22. Gallandat Huet RC, Siemons AW, Baus D, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000;47:1207-15.
23. Hecht-Dolnik M, Barkan H, Taharka A, et al. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 2009;138:703-11.
24. Yen TS, Chan KC, Cheng YJ. Intraoperative coagulation was more interfered by HES 200/0.5 than normal saline in off-pump coronary artery bypass surgery. J Cardiovasc Surg (Torino) 2008;49:679-84.
25. Penner M, Fingerhut D, Tacke A. Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL. Infusionstherapie 1990;17:314-8.
26. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis.NEngl JMed 2008;358:125-39.
27. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11.
28. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367:124-34.
29. Raiman M, Mitchell CG, Biccard BM, et al. Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: A systematic review and meta-analysis. Eur J Anaesthesiol 2016;33:42-8.
30. Kheterpal S, Tremper KK, EnglesbeMJ, et al. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007;107:892-902.
31. Hahn RG, Lyons G. The half-life of infusion fluids: An educational review. Eur J Anaesthesiol 2016;33:475-82.
32. Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2013;CD007594.
33. Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 1987;317:150-3.
34. Legouis D, Galichon P, Bataille A, et al. Rapid occurrence of chronic kidney disease in patients experiencing reversible acute kidney injury after cardiac surgery. Anesthesiology 2017;126:39-46.
35. Demirjian S, Schold JD, Navia J, et al. Predictive models for acute kidney injury following cardiac surgery. Am J Kidney Dis 2012;59:382-9.
36. Parolari A, Pesce LL, Pacini D, et al. Risk factors for perioperative acute kidney injury after adult cardiac surgery: role of perioperative management. Ann Thorac Surg 2012;93:584-91.